United States· US:50991-783_4513db4f-e8f2-ecc6-e063-6294a90a1b17
ALA-HIST IR
A dexbrompheniramine product containing dexbrompheniramine maleate, registered in United States by Poly Pharmaceuticals, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- DEXBROMPHENIRAMINE MALEATE
- Manufacturer
- Poly Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- R06AB06
- ATC class
- Dexbrompheniramine
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc11509917830212 BLISTER PACK in 1 CARTON (50991-783-02) / 1 TABLET in 1 BLISTER PACK
- ndc11509917836060 TABLET in 1 BOTTLE, PLASTIC (50991-783-60)
- ndc1150991-783-02
- ndc1150991-783-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
318 interactions on record for dexbrompheniramine.
Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dexbrompheniramine · interactions on record
318 records
- 9 severe
- 307 moderate
- 2 minor
Most severe, free to view
- Potassium chlorideA12BA01severe
- Potassium citrateA12BA02severe
- Potassium chlorideB05XA01severe
- Sodium oxybateN01AX11severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a0e0e4ee-4e8b-493d-abda-69450574513e GET /v1/drugs/a0e0e4ee-4e8b-493d-abda-69450574513e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "2",
"substance": "DEXBROMPHENIRAMINE MALEATE",
"productndc": "50991-783",
"dosage_form": "TABLET",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "M012",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about dexbrompheniramine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.